BRIAN D MAHANA

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family FAYETTEVILLE, AR NPI 1902205248

General Payments — all program years on this page

$2,417.84

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 51
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $562.61 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $562.6119

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $165.943
Penumbra, Inc. $141.661
Abbott Laboratories $78.465
NOVARTIS PHARMACEUTICALS CORPORATION $42.573
Acerta Pharma LLC $36.942
PFIZER INC. $33.582
Medtronic, Inc. $24.551
ABIOMED $22.341
BOSTON SCIENTIFIC CORPORATION $16.571

By program year

Program yearAmountRecords
2021 $390.164
2022 $661.2910
2023 $803.7818
2024 $562.6119

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1076224064 Penumbra, Inc. $141.66 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087103940 Novartis Pharmaceuticals Corporation $13.82 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087103942 Novartis Pharmaceuticals Corporation $13.96 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087103962 Novartis Pharmaceuticals Corporation $14.79 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092593557 Boston Scientific Corporation $16.57 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100239134 Novo Nordisk Inc $21.01 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100281822 Novo Nordisk Inc $19.92 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100540074 Novo Nordisk Inc $125.01 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105403998 AstraZeneca Pharmaceuticals LP $14.09 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105514575 AstraZeneca Pharmaceuticals LP $22.85 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117008154 Medtronic, Inc. $24.55 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125328598 Abbott Laboratories $14.26 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125328600 Abbott Laboratories $18.44 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125328602 Abbott Laboratories $15.23 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125328604 Abbott Laboratories $15.30 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125328606 Abbott Laboratories $15.23 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130970443 PFIZER INC. $17.61 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131047667 PFIZER INC. $15.97 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142308633 ABIOMED $22.34 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.